SIG Asia took part in the $11.7m second tranche of the compliance software developer's series A round, taking it to $19.2m.
On-demand bus transportation service Swat secured $10.1m in a round backed by public transit operators SMRT and ComfortDelGro that will fund geographical expansion and recruitment.
Brii Biosciences was among the participants in a series A round for infectious disease drug developer AN2 and has secured Chinese commercialisation rights for the startup's lead asset.
Novartis, Bayer, Evotec, Merck Group and Alexandria Real Estate Equities all invested in Longwood Fund-founded cancer immunotherapy startup Immunitas Therapeutics.
Biomedical materials firm Haohai Healthcare put up $14m for Recros Medica, which is commercialising a new plastic surgery technique for improving the smoothness of skin.
IIH Healthcare was among the investors in a series A round raised as Lucence prepares to launch its first precision medicine screening test for cancer.
The healthcare data analysis platform developer has secured $10.4m in a round featuring corporate backers Miraca and Digital Garage.
Each Friday the Global Corporate Venturing Deal Net rounds up the week’s smaller deals and tracks the emerging companies accessing corporate funds.
The e-commerce firm has agreed to pay approximately $21m for a 30% stake in Mengniu Dairy's delivery service spinoff, in a deal set to close by the end of next year.
Tridge, an agriculture networking and intelligence service for developing farmers, has raised $10.5m in its inaugural funding round, from investors reportedly including SoftBank.